Fuan Pharmaceutical (Group)co.,Ltd — Investor Relations & Filings
Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2024年度股东大会决议公告 | 2025-05-15 | Chinese | |
| 董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告 | 2025-04-23 | Chinese | |
| 2024年年度审计报告 | 2025-04-23 | Chinese | |
| 2024年度财务决算报告 | 2025-04-23 | Chinese | |
| 2024年度控股股东及其他关联方占用资金情况专项审核报告 | 2025-04-23 | Chinese | |
| 2024年度独立董事述职报告(熊文说-已离任) | 2025-04-23 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36138770 | 2024年度股东大会决议公告 | 2025-05-15 | Chinese | ||
| 36138759 | 董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告 | 2025-04-23 | Chinese | ||
| 36138751 | 2024年年度审计报告 | 2025-04-23 | Chinese | ||
| 36138687 | 2024年度财务决算报告 | 2025-04-23 | Chinese | ||
| 36138643 | 2024年度控股股东及其他关联方占用资金情况专项审核报告 | 2025-04-23 | Chinese | ||
| 36138627 | 2024年度独立董事述职报告(熊文说-已离任) | 2025-04-23 | Chinese | ||
| 36138614 | 2024年度监事会工作报告 | 2025-04-23 | Chinese | ||
| 36138599 | 关于使用闲置自有资金进行现金管理的公告 | 2025-04-23 | Chinese | ||
| 36138584 | 2024年年度报告 | 2025-04-23 | Chinese | ||
| 36138496 | 2024年度独立董事述职报告(朱姝-已离任) | 2025-04-23 | Chinese | ||
| 36138481 | 2024年度独立董事述职报告(陈耿) | 2025-04-23 | Chinese | ||
| 36138466 | 财务管理制度(2025年4月) | 2025-04-23 | Chinese | ||
| 36138454 | 关于举行2024年度业绩网上说明会的公告 | 2025-04-23 | Chinese | ||
| 36138442 | 关于2024年度利润分配预案的公告 | 2025-04-23 | Chinese | ||
| 36138428 | 关于为子公司申请银行授信融资提供担保的公告 | 2025-04-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Fuan Pharmaceutical (Group)co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55203/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55203 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55203 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55203 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55203}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Fuan Pharmaceutical (Group)co.,Ltd (id: 55203)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.